Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Ce… (NCT04057924) | Clinical Trial Compass
RecruitingNot Applicable
Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN
France200 participantsStarted 2019-08-23
Plain-language summary
This study proposes to describe and evaluate the rate of spontaneous regression of CIN2 at 2 year of follow up in women between 18 and 39 year old. This follow-up is proposed as an alternative to the treatment of reference (conization) with a possible extension to 4 years
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* CIN2 confirmed by biopsy, age between 18 and 39 years,
* satisfactory colposcopy identifying the junction and the lesion,
* affiliated person or beneficiary of a social security scheme,
* having given their oral agreement and authorization to the processing of their data.
Exclusion Criteria:
* Pregnancy in progress,
* history of conization,
* atypical or atypical glandular cells or cancer incidentally discovered during smear,
* prophylactic vaccination against HPV,
* active systemic infection requiring treatment, history of HIV infection, congenital or acquired immunodepression,
* long-term treatment with corticosteroids or immunosuppressants, placement under safeguard of justice,
* non-compliance with protocol requirements, in particular a supposed lack of compliance with long-term follow-up